National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Dictionary of Cancer Terms
In English   En español
Page Options
Print This Page
More NCI Dictionaries
NCI Drug Dictionary

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
In English   En español

Genasense (JEN-uh-sents)

 A substance being studied in the treatment of cancer. It may kill cancer cells by blocking the production of a protein that makes cancer cells live longer and by making them more sensitive to anticancer drugs. It is a type of antisense oligodeoxyribonucleotide. Also called augmerosen, bcl-2 antisense oligodeoxynucleotide G3139, and oblimersen.



Previous Definitions:gemcitabine/cisplatin, gemcitabine/cisplatin regimen, gemtuzumab, gemtuzumab ozogamicin, Gemzar
Next Definitions:gene, gene deletion, gene expression, gene expression profiling, gene therapy

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov